Form 4: Colgate-Palmolive Director Acquires Additional Shares

John P. Bilbrey, a director of Colgate-Palmolive, acquired 231 shares of common stock at a price of $91.99 on April 1, 2025, through a deferred compensation plan.

Summary

• On April 1, 2025, John P. Bilbrey, a director of Colgate-Palmolive, acquired 231 shares of common stock.
• The acquisition was made at a price of $91.99 per share.
• The shares were acquired through a portion of the annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors.
• Following the transaction, Bilbrey directly owns 33,688 shares of Colgate-Palmolive common stock and indirectly owns 4,719 shares through a trust.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. A director acquiring shares, even through a compensation plan, is generally seen as a good sign, indicating confidence in the company's prospects. However, the impact is minimal as it's a small transaction.

Positives

• The director's participation in the Deferred Compensation Plan demonstrates confidence in the company's future.

Industry Context

Director share acquisitions are common and often viewed positively as they align management's interests with those of shareholders. This transaction is part of a deferred compensation plan, a typical benefit for non-employee directors.

Stakeholder Impact

• The transaction could have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

Colgate-Palmolive, Director, Share Acquisition, Form 4, Deferred Compensation Plan, Stock, Bilbrey